Feeds:
Posts
Comments

Posts Tagged ‘sodium clodronate’

CANCER CONSULTANTS.COM: A drug treatment called Bonefos (sodium clodronate) – that blocks the function of the cells which reabsorb bone – reduces the risk of death by 23% in men with metastatic prostate cancer, report UK researchers. READ MORE>

Read Full Post »

E-CANCER MEDICAL SCIENCE: Oral bone loss drug sodium clodronate improves overall survival in men with advanced prostate cancer, but does not reduce the risk of death in men with localised disease, according to trial results published in The Lancet Oncology. READ MORE>

Read Full Post »